Regulatory & Legal

A retired Major General leads a $2.5M effort to digitize 360,000 bounty land records, unlocking the hidden histories of early American soldiers.

In the wake of a horrific mass shooting, the Canadian Red Cross is calling for national support to help the grieving B.C. town face a long road to recovery.

In a landmark move, the FDA has removed major risk warnings from hormone therapy drugs, signaling a new era for women's health after decades of fear.

The student ombudsman's latest report reveals rising complaints over school capacity and safety, highlighting systemic strains in Quebec's education system.

F/m Investments just launched a fund that's both an ETF and a mutual fund. Here's why this regulatory first is a game-changer for the entire industry.

With a new chair from Genmab and a board of industry titans, BioNJ is poised to bolster New Jersey's status as a global biotech powerhouse.

Ottawa is set to announce a major funding initiative in Saint John, partnering with local non-profits to steer at-risk youth away from crime and gangs.

VisionWave Holdings is leveraging a breakthrough in non-line-of-sight detection to compete for a piece of the Pentagon's new $13.4 billion autonomy budget.

Due to massive investor demand, Western Copper and Gold upsized its financing to C$80M, fueling the critical next steps for its giant Casino copper-gold project.

22 new experts join InCommon committees to tackle academia's top cyber threats and shape the future of secure digital collaboration worldwide.

Granted a 180-day extension, the APAC entertainment firm battles a low stock price despite revenue growth and strategic pivots in a booming market.

NanaWall's MultiSlide 630 meets Florida's tough codes, blending expansive design with the critical safety and resilience architects need in coastal regions.

A new deal for a massive compressed air energy storage plant in California aims to solve grid woes and meet the surging power demands of AI.

A NASDAQ-listed firm merges with a blockchain powerhouse, signaling a major shift for real-world asset tokenization and the future of finance.

A Canadian-made prostate treatment wins a major innovation award as new U.S. Medicare reimbursement positions it for explosive market growth.

A new plant-derived drug shows promise in preventing prostate cancer and improving cholesterol, but the company faces significant financial hurdles ahead.

The iconic brand is pivoting from its print legacy to a diversified lifestyle empire, and it has a new plan to convince investors it's the right move.

The casino giant posts a strong Q4 profit, reversing a prior year loss, as Macau's mass market boom and European expansion offset challenges in Manila.

Enhabit and Encompass Health collect millions in damages after a court found former execs committed 'egregious breaches of loyalty' to form a rival.

A new diagnostic tool for interstitial lung disease receives FDA Fast Track, promising earlier, more accurate detection of deadly lung inflammation.